Company / Interest Expense per Share
Repligen Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$400.38
FY2025
5-year range
$20.22 / $400.38
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
#1 of 43
Health Care
What the data says
Among 43 Health Care companies, Repligen is in the bottom 2% for interest expense per share. Interest Expense per Share has increased for 3 consecutive years, from $20.22 in FY2022 to $400.38 in FY2025.
Based on SEC 10-K filings.
400.38 in FY2025 with a 5-year CAGR of +14.9%. Ranks 1st among 43 companies in Health Care.
Increased from $177.54 to $400.38 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +170.5%
- 5-Year CAGR
- +14.9%
- 10-Year CAGR
- -
Sector benchmark
+3986.6% above sector average
Key checks
Key Insights
- Repligen's interest expense per share has grown for 3 consecutive years.
- In FY2025, interest expense per share increased 2.9% year-over-year.
- Ranks #1 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $400.38 | +2.9% |
| FY2024 | $389.10 | +119.2% |
| FY2023 | $177.54 | +777.8% |
| FY2022 | $20.22 | -89.7% |
| FY2021 | $196.95 | -1.4% |
| FY2020 | $199.81 | +105708.3% |
| FY2019 | $0.19 | +28.0% |
| FY2018 | $0.15 | -22.5% |
| FY2017 | $0.19 | +66.4% |
| FY2016 | $0.11 | +7396.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026